LABTLakewood-Amedex Biotherapeutics Inc.vs its industry peers
A metric-by-metric comparison of Lakewood-Amedex Biotherapeutics Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LABTThis | $5M#8 | — | 1.2x#5 | — | — | — | — | 0.0%#2 | — | — | — | — |
| BOLT | $7M#1 | — | 0.6x#1 | 0.9x#3 | 0.1%#4 | 47.1%#5 | -469.3%#5 | -264.1%#7 | — | — | -28.8%#1 | — |
| SYBX | $7M#2 | — | 0.6x#2 | — | -100.0%#7 | 95.7%#2 | — | -8.4%#3 | — | — | -63.8%#4 | — |
| ENVB | $7M#3 | — | 0.8x#4 | 0.2x#1 | -7.2%#5 | 26.0%#9 | -22.0%#1 | 149.7%#1 | -100.4%#1 | 3#2 | -80.1%#7 | — |
| ERNA | $6M#4 | 0.1x#1 | 2.0x#7 | 11.0x#6 | 755.9%#1 | 68.4%#4 | -1601.2%#6 | -440.1%#8 | -1016.2%#4 | — | -87.4%#8 | — |
| PCSA | $5M#6 | 2.9x#2 | — | — | — | 214.5%#1 | — | — | — | — | -62.5%#3 | 0.8%#1 |
| PULM | $5M#7 | — | 2.0x#8 | 0.7x#2 | 7.0%#3 | 46.0%#6 | -66.2%#2 | -201.9%#5 | -235.7%#2 | — | -71.6%#5 | — |
| XBIO | $5M#9 | — | 0.8x#3 | 1.7x#5 | 19.0%#2 | 32.3%#8 | -95.2%#3 | -44.1%#4 | -1516.8%#5 | 4#1 | -32.8%#2 | — |
| PRPH | $6M#5 | — | — | 1.3x#4 | -35.8%#6 | 72.4%#3 | -415.4%#4 | — | -804.6%#3 | — | — | — |
| DRMA | $5M#10 | — | 1.3x#6 | — | — | 38.5%#7 | — | -216.7%#6 | — | — | -79.5%#6 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice